CERTICAN 1.0 MG TABLETSView full screen / Print PDF » Download PDF ⇩
Certican 0.25 mg tablets
Certican 0.5 mg tablets
Certican 0.75 mg tablets
Certican 1.0 mg tablets
Read all of this leaflet carefully before you start taking this medicine because it contains
important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them,
even if their signs of illness are the same as yours.
• If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.
What is in this leaflet:
1. What Certican is and what it is used for
2. What you need to know before you take Certican
3. How to take Certican
4. Possible side effects
5. How to store Certican
6. Contents of the pack and other information
What Certican is and what it is used for
The active substance of Certican is everolimus.
Everolimus belongs to a group of medicines called immunosuppressants. It is used to prevent the
body’s immune system from rejecting a transplanted kidney, heart or liver.
Certican is used together with other medicines, such as ciclosporin for kidney and heart
transplantation, tacrolimus for liver transplantation, and corticosteroids.
What you need to know before you take Certican
Do not take Certican
if you are allergic (hypersensitive) to everolimus or any of the other ingredients of Certican
listed in section 6 of this leaflet.
if you are allergic (hypersensitive) to sirolimus.
If any of the above applies to you, tell your doctor and do not take Certican.
Warnings and precautions
Talk to your doctor before taking Certican:
Medicines that suppress the immune system like Certican reduce your body´s ability to fight
against infections. It is advisable to consult your doctor or transplant centre if you have a fever
or generally feel unwell, or have local symptoms such as coughing or a burning sensation when
urinating that are severe or persistent over several days. Consult your doctor or transplant centre
right away if you feel confused, have problems speaking, memory loss, a headache, impaired
vision or seizures, as these may be symptoms of a rare but very serious condition called
progressive multiple leukoencephalopathy (PML).
If you have had recent major surgery, or if you still have an unhealed wound following surgery,
Certican may increase the risk of wound-healing problems.
Medicines that suppress the immune system like Certican increase the risk of developing
cancers, particularly of the skin and the lymphoid system. Therefore, you should limit your
exposure to sunlight and UV light by wearing appropriate protective clothing and frequently
applying a sunscreen with a high protection factor.
Your doctor will monitor your kidney function, the amounts of fats (lipids) and sugar in your
blood as well as the amount of proteins in your urine.
If you have liver problems or have ever had a disease which may have affected your liver,
please tell your doctor. Your doctor may need to modify the dose of Certican you are taking.
If you experience respiratory symptoms (e.g. coughing, difficulty in breathing and wheezing),
please inform your doctor. Your doctor may decide whether and how you need to continue
Certican, and/or whether you need to receive other medicines to resolve this condition.
Certican may reduce sperm production in men, thereby reducing the ability to father children.
The effect is generally reversible. Male patients wanting to father children should discuss their
treatment with their physician.
Other medicines and Certican
Tell your doctor or pharmacist if you are taking or have recently taken or might take any other
medicines, including medicines obtained without a prescription.
Certain medicines may affect the way in which Certican works in the body. It is very important that
you tell your doctor if you are taking any of the following medicines:
immunosuppressive medicines other than ciclosporin, tacrolimus or corticosteroids.
antibiotics, such as rifampicin, rifabutin, clarithromycin, erythromycin or telithromycin.
antiviral medicines, such as ritonavir, efavirenz, nevirapine, nelfinavir, indinavir or amprenavir,
which are used to treat HIV infection.
medicines used to treat fungal infections, such as voriconazole, fluconazole, ketoconazole or
medicines used to treat epilepsy, such as phenytoin, phenobarbital or carbamazepine.
medicines used to treat high blood pressure or heart problems, such as verapamil, nicardipine or
dronedarone, a medicine used to help regulate your heart beat.
medicines used to lower blood cholesterol, such as atorvastatin, pravastatin or fibrates.
medicines used to treat acute seizures, or used as a sedative before or during surgery or other
medical procedures, such as midazolam.
octreotide, a medicine used to treat acromegaly, a rare hormonal disorder that usually occurs in
imatinib, a medicine used to inhibit the growth of abnormal cells.
St. John’s wort (Hypericum perforatum), a herbal medicine used to treat depression.
If you need to have a vaccination, talk to your doctor first.
Certican with food and drink
The presence of food can affect how much Certican is absorbed. In order to keep constant levels in
your body, you should always take Certican in the same way. You should either always take it with
food, or always on an empty stomach.
Do not take Certican with grapefruit juice or grapefruit. They affect how Certican works in the body.
Pregnancy, breast-feeding and fertility
If you are pregnant, do not take Certican unless your doctor thinks it is absolutely necessary. If you are
a woman and you could get pregnant, you should use an effective method of contraception during
treatment with Certican and for 8 weeks after stopping treatment.
If you think you may be pregnant, ask your doctor or pharmacist for advice before taking Certican.
You should not breast-feed while taking Certican. It is not known whether Certican passes into breast
Certican may have an impact on male fertility.
Driving and using machines
No studies on the effects on the ability to drive and use machines have been performed.
Certican tablets contain lactose. If you do not tolerate certain sugars (glucose, galactose, lactose), you
should talk to your doctor before taking Certican.
How to take Certican
Your doctor will decide exactly what dose of Certican you should take and when you should take it.
Always take Certican exactly as your doctor or pharmacist has told you. Check with your doctor or
pharmacist if you are not sure.
How much to take
The usual starting dose is 1.5 mg/day in kidney and heart transplantation and 2.0 mg/day in liver
This is usually divided into two doses, one in the morning and one in the evening.
How to take Certican
Certican should only be taken by mouth.
Do not crush the tablets.
Swallow the tablets whole with a glass of water.
You should take the first dose of this medicine as early as possible after kidney and heart
transplantation and approximately four weeks after liver transplantation.
You should take the tablets together with ciclosporin for microemulsion in kidney and heart
transplantation, and with tacrolimus in liver transplantation.
Do not switch from Certican tablets to Certican dispersible tablets without first telling your doctor.
Monitoring during your treatment with Certican
Your doctor may adjust your dose depending on how much Certican there is in your blood and
depending on how well you respond to the treatment. Your doctor will perform regular blood tests to
measure the amount of everolimus and ciclosporin in your blood. Your doctor will also carefully
monitor your kidney function, blood lipids and blood sugar, as well as the amount of proteins in your
If you take more Certican than you should
If you take more of this medicine than you should, talk to your doctor immediately.
If you forget to take Certican
If you have forgotten to take your dose of Certican, take it as soon as you remember and then take the
next dose at the usual time. Ask your doctor for advice. Do not take a double dose to make up for a
If you stop taking Certican
Do not stop taking the tablets unless your doctor tells you to. You will need to take this medicine for
as long as you need to have immunosuppressants to prevent the rejection of your transplanted kidney,
heart or liver. If you stop taking Certican, you will have a greater risk of your body rejecting the
Older people (65 years and over)
There is limited experience with the administration of Certican in elderly people.
Children and adolescents (2-17 years of age)
Certican is not recommended for use in children and adolescents because there is not enough
experience in the use of Certican in this age group.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Possible side effects
Like all medicines, Certican can cause side effects, although not everybody gets them.
Because you take Certican together with other medicines, it is not always clear whether the side effects
are caused by Certican or by the other medicines.
The following side effects need immediate medical attention:
inflammation of the lungs,
fever and bruising under the skin that may appear as red dots, with or without unexplained
tiredness, confusion, yellowing of the skin or eyes, reduced urine output (thrombotic
microangiopathy, haemolytic uraemic syndrome).
Should you develop any of the following:
persistent or worsening lung/breathing symptoms such as coughing, difficulty breathing, or
fever, generally feeling unwell, chest or abdominal pain, chills, burning sensation when
swelling of face, lips, tongue or throat,
spontaneous bruising or bleeding for no obvious reason,
pain, unusual warmth, swelling or oozing from the site of surgery
you should stop taking Certican and tell your doctor straight away.
Other reported side effects include:
Very common (may affect more than 1 in 10 patients)
infections (viral, bacterial and fungal infections),
lower respiratory tract infections, such as lung infections, including pneumonia
upper respiratory tract infections, such as inflammation of the pharynx, and common cold,
urinary tract infections,
anaemia (reduced red blood cell count),
low levels of white blood cells, leading to a higher risk of infection,reduced blood platelet
count, which can lead to bleeding and/or bruising underneath the skin,
high level of fats (lipids, cholesterol and triglycerides) in the blood,
onset of diabetes (high level of sugar in the blood),
reduced level of potassium in the blood,
problems falling asleep (insomnia),
fluid collection in the sac around the heart, which if severe, can decrease the heart's ability to
high blood pressure,
venous thrombosis (blockage of a major vein by a blood clot),
fluid collection on the lungs and in the chest cavity, which, if severe, could make you breathless,
feeling sick (nausea),
being sick (vomiting),
stomach (abdominal) pain,
accumulation of fluid in the tissues,
abnormal wound healing.
Common (may affect up to 1 in 10 patients)
cancers and benign tumours,
kidney damage with low blood platelets and low red blood cell counts, with or without a rash
(thrombocytopenic purpura/haemolytic uraemic syndrome),
breakdown of red blood cells,
low levels of red blood cells and platelets,
fast heart beat,
reduced numbers of blood cells (symptoms may include weakness, bruising and frequent
clotting in the blood vessels of the kidney, which may result in graft loss mostly within the first
30 days after kidney transplantation,
cyst containing lymph fluid,
pain in the mouth or throat,
inflammation of the pancreas,
hives (urticaria) and other allergic symptoms, such as swelling of the face or throat
protein in the urine,
hernia at the site of surgery,
abnormal liver test results.
Uncommon (may affect up to 1 in 100 patients):
cancer of the lymph tissue (lymphoma/post-transplant lymphoproliferative disorder),
low levels of testosterone,
inflammation of the lungs,
inflammation of the liver,
Other side effects:
Other side effects have occurred in a small number of people, but their exact frequency is unknown:
• abnormal accumulation of protein in the lungs (symptoms may include persistent dry cough,
fatigue and difficulty breathing),
inflammation of blood vessels,
severe rash with skin swelling.
If you have concerns regarding any of these effects, tell your doctor.
There may also be side effects of which you are not aware, such as abnormal results of laboratory
tests, including tests of kidney function. This means that your doctor will perform blood tests to
monitor any changes to your kidneys during your treatment with Certican.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects
not listed in this leaflet. You can also report side effects directly via the internet
at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on
the safety of this medicine.
How to store Certican
Keep Certican out of the sight and reach of children.
Do not use Certican after the expiry date which is stated on the carton after EXP. The expiry
date refers to the last day of that month.
Store the blister packs in the original carton in order to protect from light and moisture.
Do not use any Certican pack that is damaged or shows signs of tampering.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how
to throw away medicines you no longer use. These measures will help protect the environment.
Content of the pack and other information
What Certican contains
The active substance is everolimus. Each tablet contains 0.25, 0.5, 0.75 or 1.0 mg everolimus.
The other ingredients are:
- Certican 0.25 mg tablets: butylhydroxytoluene (E321), magnesium stearate, lactose
monohydrate (2 mg), hypromellose, crospovidone and anhydrous lactose (51 mg).
- Certican 0.5 mg tablets: butylhydroxytoluene (E321), magnesium stearate, lactose
monohydrate (4 mg), hypromellose, crospovidone and anhydrous lactose (74 mg).
- Certican 0.75 mg tablets: butylhydroxytoluene (E321), magnesium stearate, lactose
monohydrate (7 mg), hypromellose, crospovidone and anhydrous lactose (112 mg).
- Certican 1.0 mg tablets: butylhydroxytoluene (E321), magnesium stearate, lactose
monohydrate (9 mg), hypromellose, crospovidone and anhydrous lactose (149 mg).
What Certican looks like and contents of the pack
Certican 0.25 mg tablets are white to yellowish, marbled, round, flat tablets engraved “C” on
one side and “NVR” on the other.
Certican 0.5 mg tablets are white to yellowish, marbled, round, flat tablets, engraved “CH” on
one side and “NVR” on the other.
Certican 0.75 mg tablets are white to yellowish, marbled, round, flat tablets, engraved “CL” on
one side and “NVR” on the other.
Certican 1.0 mg tablets are white to yellowish, marbled, round, flat tablets, engraved “CU” on
one side and “NVR” on the other.
Certican tablets are supplied in packs containing 50, 60, 100 or 250 tablets. Not all pack sizes may be
marketed. Certican is also available in the form of dispersible tablets.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
Novartis Pharmaceuticals UK Limited
Frimley Business Park
Surrey, GU16 7SR
Novartis Pharma GmbH
This medicinal product is authorised in the Member States of the EEA under the following
Certican: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland,
France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Malta,
Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia , Spain, Sweden, United
This leaflet was last revised in October 2014
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.